Quick Answer
CITIUS ONCOLOGY, INC. reported Shares Outstanding of 83.51 million shares for fiscal year 2025.
CITIUS ONCOLOGY, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 83.51M | +16.7% |
| 2024 | 71.55M | +2956.5% |
| 2023 | 2.34M | -96.5% |
| 2023 | 67.50M | +2693.9% |
| 2022 | 2.42M | +0.0% |
| 2021 | 2.42M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| December 31, 2025 | 84.80M | +18.5% | +1.5% |
| September 30, 2025 | 83.51M | +16.7% | +16.7% |
| June 30, 2025 | 71.55M | +2956.5% | +0.0% |
| March 31, 2025 | 71.55M | +2956.5% | +0.0% |
| December 31, 2024 | 71.55M | +2956.5% | +0.0% |
| September 30, 2024 | 71.55M | +2956.5% | +2956.5% |
| June 30, 2024 | 2.34M | -3.1% | +0.0% |
| March 31, 2024 | 2.34M | -3.1% | +0.0% |
- CITIUS ONCOLOGY, INC. showed an increase of +16.7% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2025 period, CITIUS ONCOLOGY, INC.’s shares outstanding has grown by 3356.7% (from 2.42 million shares to 83.51 million shares).
- The most recent figure is from CITIUS ONCOLOGY, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on December 23, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: